A baby born with a rare eye cancer — typically diagnosed only after symptoms develop in early childhood — is among the growing number of newborns receiving earlier diagnoses and life-changing treatment through the Generation Study. This world-leading research programme, led by Genomics England in partnership with NHS England, uses whole-genome sequencing (WGS) to screen 100,000 newborns for over 200…
Ben KempOctober 28, 2025


